Sort
4,870 grants matching “glp 1”
Regulation of islet gap junction coupling and function under inflammatory conditions
$59,970Nikki L. Farnsworth · University Of Colorado Denver · F32 · FY2016 · DK
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 1/14/16)
$59,791Alan Carter · Midwest Research Institute · N01 · FY2022 · DA
Clinical Evaluation of a Personalized Vaccine Immunotherapy in Combination with Checkpoint Inhibitors for Triple Negative Breast Cancer
$59,382Christopher D Pack · Metaclipse Therapeutics Corporation · R44 · FY2022 · CA
Leptin and development of glucagon-like peptide-1(GLP-1)neural circuits controlling ingestive behavior
$59,166Jessica Erin Biddinger · Vanderbilt University · F32 · FY2017 · DK
The Role of Islet DPP4 for Regulation of Glucose Homeostasis
$58,654Megan Capozzi · Duke University · F32 · FY2018 · DK
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 1/14/16)
$58,169Alan Carter · Midwest Research Institute · N01 · FY2021 · DA
Nutritional and Hormonal Mechanisms of Intestinal Adaptation
$57,190Denise M Ney · University Of Wisconsin-Madison · R56 · FY2011 · DK
Manufacturing and Toxicology Studies of DNA and Protein Vaccines
$57,121Gary R Ostroff · Univ Of Massachusetts Med Sch Worcester · U19 · FY2013 · AI
Phase 2 Study: Intranasal Oxytocin vs. Placebo for the Treatment of Hyperphagia in Prader-Willi Syndrome [IND 121109 acknowledged 8/27/14]
$57,079Eric Hollander · Albert Einstein College Of Medicine, Inc · R01 · FY2018 · FD
Role of Novel Branched Chain Fatty Acids in Amelioration of Metabolic Disease
$57,066Meric Erikci Ertunc · Salk Institute For Biological Studies · F32 · FY2017 · DK
Development of a lipid-based platform for mucosal delivery and mucosal vaccination
$57,066Maria Daniela Garcia-Castillo · Boston Children'S Hospital · F32 · FY2017 · DK
Development of a lipid-based platform for mucosal delivery and mucosal vaccination
$56,994Maria Daniela Garcia-Castillo · Boston Children'S Hospital · F32 · FY2016 · DK
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 1/14/16)
$56,580Alan Carter · Midwest Research Institute · N01 · FY2020 · DA
GLP-1 Effects in Water and Salt Intake
$56,230Derek Daniels · State University Of New York At Buffalo · R01 · FY2017 · DK
Targeting chemoresistant prostate cancer with novel EED inhibitors
$56,208Daqing Wu · Clark Atlanta University · R01 · FY2024 · CA
Leptin and development of glucagon-like peptide-1(GLP-1)neural circuits controlling ingestive behavior
$56,118Jessica Erin Biddinger · Vanderbilt University · F32 · FY2016 · DK
Regulation of islet gap junction coupling and function under inflammatory conditions
$56,042Nikki L. Farnsworth · University Of Colorado Denver · F32 · FY2015 · DK
Regulation of Intestinal PYY cell function
$55,858Diego V Bohorquez · Duke University · F32 · FY2013 · DK
Metabolic Consequences of Neonatal Programming by a GLP1 Receptor Agonist
$55,742Daniella Angela Babu · University Of Pennsylvania · F32 · FY2011 · DK
Regulation of Intestinal PYY cell function
$55,094Diego V Bohorquez · Duke University · F32 · FY2014 · DK
Role of GLP-1 in Type 2 Diabetes Improvement After Roux-en-Y Gastric Bypass
$55,094Jill Carmody · Massachusetts General Hospital · F32 · FY2014 · DK
IGF::OT::IGF DRUG MANUFACTURING AND FORMULATION PROGRAM (DMFP) TASK ORDER #01: PERFORMANCE ACTIVITY 1 TECHNICAL SUPPORT (1/15/15 1/14/16)
$55,056Alan Carter · Midwest Research Institute · N01 · FY2019 · NS
Self-sealing needle guide system for reliable hemodialysis
$55,000Jason Bobe · Flowpoint Medical Inc · R43 · FY2025 · DK
A 3-month Release Naltrexone for Addiction Treatment
$55,000Timothy D Heath · Plumb Pharmaceuticals, Inc · R43 · FY2019 · DA
Microneedle Based Targeted Allergen Specific Immunotherapy for Treatment of Peanut Allergies
$55,000Samirkumar Patel · Moonlight Therapeutics, Inc. · R42 · FY2020 · AI